Frontage Holdings Corporation (FGHQF)
OTCMKTS · Delayed Price · Currency is USD
0.1400
0.00 (0.00%)
At close: Feb 6, 2026
Frontage Holdings Revenue
Frontage Holdings had revenue of $126.58M in the half year ending June 30, 2025, a decrease of -1.39%. This brings the company's revenue in the last twelve months to $253.01M, down -2.68% year-over-year. In the year 2024, Frontage Holdings had annual revenue of $254.91M, down -1.90%.
Revenue (ttm)
253.01M
Revenue Growth
-2.68%
P/S Ratio
1.11
Revenue / Employee
164.29K
Employees
1,540
Market Cap
280.13M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 254.91M | -4.95M | -1.90% |
| Dec 31, 2023 | 259.86M | 9.50M | 3.79% |
| Dec 31, 2022 | 250.36M | 65.92M | 35.74% |
| Dec 31, 2021 | 184.44M | 58.63M | 46.60% |
| Dec 31, 2020 | 125.81M | 25.40M | 25.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BioStem Technologies | 292.21M |
| Vaxart | 148.20M |
| Silence Therapeutics | 25.83M |
| Nuo Therapeutics | 2.61M |
| Northwest Biotherapeutics | 937.00K |
| ZIVO Bioscience | 209.03K |